17
Top mass tort topics of interest September 2015

Current and Emerging Topics in Mass Torts

Embed Size (px)

Citation preview

Page 1: Current and Emerging Topics in Mass Torts

Top mass torttopics of interest

September 2015

Page 2: Current and Emerging Topics in Mass Torts

XareltoManufacturer:

Janssen Pharmaceuticals

MDL: Eastern District of Louisiana, Judge Fallon

Active Lead Generation: We are actively generating Xarelto leads. Please contact me for current pricing.

Issue/Injury:

Anticoagulant that is advertised as a better alternative to Warfarin because patients are not required to go into a clinic for regular blood testing. There is no known antidote to get the blood to clot, if needed. The "no blood test" claim with the no antidote available exposes patients to a much greater risks of suffering from a severe bleeding event. The injuries we are targeting include: severe bleeding events, gastrointestinal bleeding, cerebral hemorrhaging, and death.

Page 3: Current and Emerging Topics in Mass Torts

TRT (testosterone replacement therapy)

Manufacturers: Abbvie is the main defendant but other defendants are involved.

MDL: Northern District of Illinois, Judge Kennelly

Active Lead Generation: We are actively generating TRT leads. Please contact me for current pricing.

Issue/ Injury: Extremely popular prescribed testosterone medications, like AndroGel, have now been shown to cause strokes, pulmonary embolisms, heart attacks, blood clots, osteonecrosis, and death.

Brands: AndroGel, Androderm, Axiron, Fortesta, Striant, Bio-T-Gel, Testim, Testospel

Page 4: Current and Emerging Topics in Mass Torts

IVC FilterManufacturers:

Bard and Cook

MDL: Cook Medical - Southern District of IndianaBard – District of Arizona

Active Lead Generation:We are actively generating IVC Filter leads. Please contact me for current pricing.

Injury: Fractures- Legs on the device fracture, then

break, and migrate to the body. Migration- The device migrates outside the IVC

and into the body. Perforation- the legs of device puncher the

wall of the vein.

Issue: The device was meant to be put into patients if they have a serious risk of thrombotic event. The device is not meant to be left in for a long period of time. Fractures, migration, and perforation are much more likely if the device is left in longer than 6 months.

Page 5: Current and Emerging Topics in Mass Torts

LipitorManufacturer:

Pfizer

Total Sales:$131 Billion

MDL: District of South Carolina, Judge Gergel

Active Lead Generation: We are actively generating Lipitor leads. Please contact me for current pricing.

Issue/Injury: Lipitor is being linked to a significant rise in blood sugar levels which can lead to the development of type 2 diabetes in women, particularly women who have gone through menopause.

Page 6: Current and Emerging Topics in Mass Torts

RisperdalManufacturers:

Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson.

Issue/Injury: This atypical antipsychotic drug was promoted to be used on children before the company had FDA approval. Johnson and Johnson has agreed to pay $2.2 billion to settle charges with the U.S. Department of Justice for the illegal marketing of the drug. The injury firms are investigating is the link between males who suffer from gynecomastia (breast growth) after taking Risperdal.

MDL: Consolidation has begun in Philadelphia but no official MDL has been established.

Active Lead Generation: We are actively generating Risperdal leads. Please contact me for current pricing.

Page 7: Current and Emerging Topics in Mass Torts

ZofranManufacturer:

GlaxoSmithKline

MDL: Currently no MDL has been formed.

Active Lead Generation:

We are actively generating Zofran leads. Please contact me for current pricing.

Issue/ Injury: Zofran is an anti-nausea medication approved by the FDA in 1991 to help cancer patients undergoing chemotherapy and radiation treatment and also post surgery patients.

In 2012, the U.S. Department of Justice sued Glaxo for fraud because it illegally promoted this drug for use in pregnant women. It was being promoted for off-label use for women suffering from morning sickness and won a settlement of $3 billion—the largest drug fraud settlement ever. There has been links to birth injury if Zofran is taken within the first trimester. Injuries include cleft lip, cleft palate, heart defects, atrial fibrilllation, septal defects & even deaths.

Page 8: Current and Emerging Topics in Mass Torts

BenicarManufacturer :

Daiichi Sankyo

MDL: District Court of New Jersey, Judge Kugler

Active Lead Generation: We are actively generating Benicar leads. Please contact me for current pricing.

Issue/Injury:Benicar is a prescription medication created for the treatment of high blood pressure. Patients who are taking Benicar have developed spur like enteropathy and are suffering from severe chronic diarrhea, nausea, vomiting, severe weight loss, and malnutrition.

Page 9: Current and Emerging Topics in Mass Torts

Talc PowderManufacturer:

Johnson and Johnson

MDL:Currently no MDL has been formed.

Active Lead Generation: We are actively generating Talc Powder leads. Please contact me for current pricing.

Issues/ Injuries: A Sioux Falls, South Dakota federal jury found that J&J’s talc powder was the cause for the development of a women’s ovarian cancer in 2013. Studies showing a higher rate of the disease with talc use have typically found an increased risk of about 35 percent, this puts the odds at about one in 50.

Page 10: Current and Emerging Topics in Mass Torts

Essure Manufacturer: Bayer

Issue/ injury: Essure permanent birth control is know to cause Ectopic

pregnancies, perforation, puncture of internal organs, and infections among

women who have had the device implanted. There are currently more than

7,000 adverse event reports that have been received by the FDA.

News: FDA's Obstetrics and Gynecology Devices Panel will convene September 24,

2015 to review (preemption issue expected to be addressed).

MDL: A few cases have been filed. No imminent JPML review or motion to

centralize has been submitted as of September 2015.

Active Lead Generation: We are actively generating Essure leads. Please contact me for current pricing.

Page 11: Current and Emerging Topics in Mass Torts

EMERGING TOPIC: PSEUDOTUMOR CEREBRI

Included Drugs:YAZ, Mirena IUD, NuvaRing, Nexpplanon, Implanon, ParaGard,Depo Provera, OrthoEvra or Gardasil

Even if your symptoms have resolved, they can recur months or even years later

Serious injuries may require a lumbar

punctures and shunts placed in the brain.

PTC is most common for women between the age of 20-50 years old.

Issue/ injury:

Women taking these birth control medications may be at risk of developing PTC. PTC literally means "false brain tumor". People with PTC have an increased amount of cerebral spinal fluid which causes pressure in the skull. This causes people to have similar symptoms to those who have brain tumors. In some cases it can causes progressively worsening vision and may eventually cause blindness.

Page 12: Current and Emerging Topics in Mass Torts

EMERGING TOPIC: bair huggerManufacturer: MDL: Motion to transfer under JPML review. Projected to be

centralized in Minnesota.

Issue/ injury: This is a forced air warming blanket that has been linked to the contamination of surgery rooms and deep joint infections. It was designed to keep patients warm during surgery, but accumulates under the surgical drape, travels to the floor, and lifts bacteria off the floor and into the surgical wound. Contaminants from the dirty floor lead to Periprosthetic Joint Infections (PJI), a serious joint infection which could lead to amputation of the limb.

Page 13: Current and Emerging Topics in Mass Torts

EMERGING TOPIC: invokanaManufacturers: Johnson & Johnson, Janssen Pharmaceuticals Inc., AstraZeneca & Boehringer Ingelheim

Issue/injury: Failed to warn patients and physicians of the increased risks of kidney failure, heart attacks, ketoacidosis, and other cardiovascular issues.

May 15, 2015: FDA put out a safety announcement that SGLT2 inhibitors may lead to Ketoacidosis

Page 14: Current and Emerging Topics in Mass Torts

EMERGING TOPIC: onglyza

This drug is in a brand new class of diabetic drugs known as DPP-4 Inhibitors used to control blood glucose levels in type 2 diabetes

patients.Manufacturer: AstraZenecaFebruary 11, 2014: FDA issued a safety communication as a result of a New

England Journal of Medicine study that reported that patients are at an increased risk of heart attack while taking Saxagliptin (marketed as Onglyza an Kombiglize).

April 14, 2015: FDA's Endocrinologic and Metabolic Advisory Committee voted 14-1 in favor of changing the drug's label in light of results from a post-marketing study that found Onglyza was associated with a 27% increase in hospitalizations for heart failure as well as a higher risk of all-cause mortality.

Issue/Injury: Congestive Heart Failure (CHF), Myocardial Infraction, Stroke, Unstable Angina & Heart Failure

Page 15: Current and Emerging Topics in Mass Torts

EMERGING TOPIC: eliquis (apixaban)Manufactur

ers:Bristol-Myers

Squibb& Pfizer

*Newer generation

anticoagulant medication

that does not currently have an

approved antidote.

Very similar to Xarelto

and Pradaxa. 

Injuries: Internal Bleeding Cerebral Bleeding Kidney Bleeding Uncontrollable Bleeding Death as a result of Bleeding

Page 16: Current and Emerging Topics in Mass Torts

EMERGING TOPIC: Ppi drugsPrilosec, Prevacid, Nexium and others.

A Stanford Medicine data mining study linked heartburn drugs to an increase risk of heart attack.

Researchers found that people who take the medication to suppress the release of stomach acid are 16 percent to 21 percent more likely to suffer myocardial infarction

More than 100 million prescriptions filled annually in US.

Over 20 million users in the U.S., which is around one out of every 14 people.

PPI’s have global annuals sales of over$14 Billion a annually.

Page 17: Current and Emerging Topics in Mass Torts

contact informationWe are currently generating quality leads through multimedia

campaigns and providing intake services with NO BACKEND FEES!

Please contact me to discuss current pricing and options.

Sarai MoraBusiness Advisor

Mass Tort Legal GroupC: (619) 306-9339

[email protected]